Clinical Trials · NCT00209261

A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)

Name: A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Desmopressin

Phase: Phase 4
Recruitment status: Completed
Sponsor: Ferring Pharmaceuticals
Enrollment: 221
Start date: Dec 2004
Locations: 1 site, France
Primary endpoint: The primary endpoint will be the difference in the proportion of subjects who preferred each formulation at the end of the 6-week treatment period.

View Desmopressin compound reference